secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2022-11-04T23:59:59+00:00
Accession:  0001493152-22-030706
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics receives Nasdaq delisting notice for bid price below $1.00
-----------------------------------------------------------------------------

- Received deficiency notice on Nov 3, 2022 for bid price below $1.00 for 30 consecutive days (Sep 22–Nov 2, 2022).
- Has 180 days, until May 2, 2023, to regain compliance with closing bid ≥ $1.00 for 10 consecutive business days.
- If not cured, may qualify for additional 180-day grace period if meeting other listing standards.
- Management intends to resolve deficiency to maintain listing on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315222030706/0001493152-22-030706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315222030706/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-030706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer